Meeting
2016 Cancer Survivorship Symposium
Late-stage lung cancer patient preferences about chemotherapy treatment adverse side effects.
Authors
K. M Islam
University of Nebraska Medical Center, Omaha, NE
K. M Islam , June Ryan , Ann Fetrick , Apar Kishor Ganti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Care Coordination and Financial Implications,Communication,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Recurrence and Secondary Malignancies
Sub Track
Communicating with Patients/Families/Caregivers
Citation
J Clin Oncol 34, 2016 (suppl 3S; abstr 93)
DOI
10.1200/jco.2016.34.3_suppl.93
Abstract #
93
Poster Bd #
M1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Uptake of palliative care services in patients with non-small cell lung cancer receiving immune checkpoint inhibitor therapy: The Mayo Clinic Florida experience.
First Author: Tanmayi Pai
Poster
2023 ASCO Genitourinary Cancers Symposium
Adrenocortical carcinoma: Report of data from 66 patients with a rare disease at a cancer center.
First Author: Rafael Haikal dos Santos Abduch
Poster
2022 ASCO Quality Care Symposium
Improving new cancer diagnosis education in a metropolitan cancer center.
First Author: Arthi Sridhar
Poster
2022 ASCO Genitourinary Cancers Symposium
US physician perceptions of treatment decision making for advanced renal cell carcinoma.
First Author: Daniel M. Geynisman